Newcastle spinout Newcells receives six-figure investment from Northstar Ventures for drug discovery platform.

The pharmaceutical company, which invested $20m in cancer drug developer ADC Therapeutics in 2013, returned to back an $80m private placement.

The cancer treatment developer has raised $165m in venture capital from investors including pharmaceutical companies Roche and Pfizer.

The funding will support the Danfoss spin-out in the run up to the commercial launch of its insulin delivery device in 2016.

Texas University joins forces with Germany-based biotech Immatics on immunotherapy spinout backed with $60m.

Anti-scarring research at British Columbia leads to the launch of BirchBioMed.

Summation Health Ventures, a fund backed by two healthcare systems, was among the investors in a round that will support commercialisation of Gauss's blood loss monitoring system.